$1.620
+0.383 (+23.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Davion Healthcare Plc Ordinary Shares Stock?
Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.
DAVI stock price ended at $1.62 on Friday, after rising +23.66%
Davion Healthcare Plc Ordinary Shares (DAVI) last closed at $1.62, gaining +23.66%. These facts feed the 1-day and 1-week DAVI price prediction above.
Forecast Drivers
Davion Healthcare Plc Ordinary Shares (DAVI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
Seasonality analysis for DAVI
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.